arabinofuranosyluracil and Fibrosarcoma

arabinofuranosyluracil has been researched along with Fibrosarcoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Avril, N; Gansbacher, B; Hantzopoulos, PA; Haubner, R; Schwaiger, M	1
Abbruzzese, JL; Castellanos, AM; Krakoff, IH; Legha, SS; Levy, JK; Raber, MN; Schmidt, S	1

Other Studies

2 other study(ies) available for arabinofuranosyluracil and Fibrosarcoma

Article	Year
In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiolabelled FIAU. European journal of nuclear medicine, 2000, Volume: 27, Issue:3 Topics: Animals; Arabinofuranosyluracil; Chromatography, High Pressure Liquid; Fibrosarcoma; Gene Expression; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Herpesvirus 1, Human; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Radionuclide Imaging; Thymidine Kinase; Tissue Distribution; Transduction, Genetic	2000
Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity. Investigational new drugs, 1989, Volume: 7, Issue:2-3 Topics: Adult; Aged; Antineoplastic Agents; Arabinofuranosyluracil; Colonic Neoplasms; Drug Evaluation; Electroencephalography; Female; Fibrosarcoma; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Nervous System Diseases; Nervous System Neoplasms	1989

Article

Year

In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiolabelled FIAU.

European journal of nuclear medicine, 2000, Volume: 27, Issue:3

Topics: Animals; Arabinofuranosyluracil; Chromatography, High Pressure Liquid; Fibrosarcoma; Gene Expression; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Herpesvirus 1, Human; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Radionuclide Imaging; Thymidine Kinase; Tissue Distribution; Transduction, Genetic

2000

Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity.

Investigational new drugs, 1989, Volume: 7, Issue:2-3

Topics: Adult; Aged; Antineoplastic Agents; Arabinofuranosyluracil; Colonic Neoplasms; Drug Evaluation; Electroencephalography; Female; Fibrosarcoma; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Nervous System Diseases; Nervous System Neoplasms

1989